ArticleScientific reports2023

Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases.

Hisashi Hirano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.